Spirit Airlines will be reducing its flight capacity by a staggering 25% year-over-year, bringing with it a wave of job cuts starting in November, according to a company memo.The devastating downsizing is being done to “optimize our network to focus on our strongest markets,” Spirit Airlines CEO Dave Davis announced to employees in the note obtained by The Post.“These evaluations will inevitably affect the size of our teams as we become a more efficient airline,” Davis acknowledged. 3 Spirit Airlines pla ...

SAN DIEGO , Sept. 18, 2025 /PRNewswire/ -- Robbins LLPÂ reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Quantum Corporation (NASDAQ: QMCO) securities between November 15, 2024 and August 18, 2025. ...

SAN DIEGO , Sept. 18, 2025 /PRNewswire/ -- Robbins LLPÂ informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. (NASDAQ: CYTK) securities between December 27, 2023 and May 6, 2025. ...

SAN DIEGO , Sept. 18, 2025 /PRNewswire/ --Â Robbins LLPÂ reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025. ...

– 89bio stockholders to receive up to $20.50 per share in cash, comprised of $14.50 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $6.00 per share in cash; transaction represents total equity value of up to approximately $3.5 billion – – Transaction reflects pegozafermin’s potential best-in-disease profile for the treatment of moderate to severe metabolic dysfunction-associated steatohepatitis (MASH) – – 89bio to join the Roche Group as part of ...

– 89bio stockholders to receive up to $20.50 per share in cash, comprised of $14.50 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $6.00 per share in cash; transaction represents total equity value of up to approximately $3.5 billion – – Transaction reflects pegozafermin’s potential best-in-disease profile for the treatment of moderate to severe metabolic dysfunction-associated steatohepatitis (MASH) – – 89bio to join the Roche Group as part of ...

OSLO, Norway (18 September 2025) – TGS, a global leader in energy data and intelligence, is pleased to announce PAMA Phase II 3D multi-client survey in the Equatorial Margin area offshore Brazil. The first phase covered 19,343 square kilometers and more than 25 future exploration blocks within the Pará-Maranhao Basin, one of the world’s largest, most unexplored, and highly prospective basins. PAMA Phase II extends coverage by approximately 11,500 square kilometers, including blocks currently under nominatio ...

89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most prevalent comorbidities of obesityAcquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination developmentRoche to acquire 89bio for US$14.50 per share in cash at closing, representing a total equity value of approximately US$ ...

Artificial intelligence reigns over Wall Street these days. Here's a list of names to play because of all the spending on data centers. ...

BEVERLY HILLS, CA / ACCESS Newswire / September 18, 2025 / Green Rain Energy Holdings (OTCID:$GREH), through its board of directors, has approved the issuance of a special stock dividend to shareholders of record. The emerging EV charging and solar energy company is poised to make great strides with this special stock dividend. ...